Industry Research Reports

Home > Reports > Medical Care > Companion Diagnostic Technologies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Companion Diagnostic Technologies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 114 Pages

Report ld: 2332899

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment.

The global market for Companion Diagnostic Technologies was estimated to be worth US$ 2771.3 million in 2023 and is forecast to a readjusted size of US$ 6057.7 million by 2030 with a CAGR of 11.3% during the forecast period 2024-2030

Companion Diagnostic Technologies Market Size

M= millions and B=billions

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Companion Diagnostic Technologies, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Companion Diagnostic Technologies by region & country, by Type, and by Application.

The Companion Diagnostic Technologies market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostic Technologies.

Market Segmentation

Report Metric
Details
Report Title
Companion Diagnostic Technologies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 6057.7 million
CAGR(2024-2030)
11.3%
Market Size Available for Years
2019-2030
Global Companion Diagnostic Technologies Companies Covered
Dako (Agilent Technologies), Qiagen, Roche, Abbott Laboratories, Thermo Fisher Scientific, bioMerieux, Myriad Genetics, Resonance Health Ltd., Leica Microsystems, Danaher
Global Companion Diagnostic Technologies Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Companion Diagnostic Technologies Market, Segment by Type
Immunohistochemistry

Molecular Diagnostics
Global Companion Diagnostic Technologies Market, Segment by Application
Oncology

Cardiovascular

Central Nervous System

Auto immune & Inflammation

Virology

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Companion Diagnostic Technologies manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Companion Diagnostic Technologies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Companion Diagnostic Technologies in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Companion Diagnostic Technologies Product Introduction
    1.2 Global Companion Diagnostic Technologies Market Size Forecast
    1.3 Companion Diagnostic Technologies Market Trends & Drivers
        1.3.1 Companion Diagnostic Technologies Industry Trends
        1.3.2 Companion Diagnostic Technologies Market Drivers & Opportunity
        1.3.3 Companion Diagnostic Technologies Market Challenges
        1.3.4 Companion Diagnostic Technologies Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Companion Diagnostic Technologies Players Revenue Ranking (2023)
    2.2 Global Companion Diagnostic Technologies Revenue by Company (2019-2024)
    2.3 Key Companies Companion Diagnostic Technologies Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Companion Diagnostic Technologies Product Offered
    2.5 Key Companies Time to Begin Mass Production of Companion Diagnostic Technologies
    2.6 Companion Diagnostic Technologies Market Competitive Analysis
        2.6.1 Companion Diagnostic Technologies Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Companion Diagnostic Technologies Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Technologies as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Immunohistochemistry
        3.1.2 Molecular Diagnostics
    3.2 Global Companion Diagnostic Technologies Sales Value by Type
        3.2.1 Global Companion Diagnostic Technologies Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Companion Diagnostic Technologies Sales Value, by Type (2019-2030)
        3.2.3 Global Companion Diagnostic Technologies Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Oncology
        4.1.2 Cardiovascular
        4.1.3 Central Nervous System
        4.1.4 Auto immune & Inflammation
        4.1.5 Virology
        4.1.6 Others
    4.2 Global Companion Diagnostic Technologies Sales Value by Application
        4.2.1 Global Companion Diagnostic Technologies Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Companion Diagnostic Technologies Sales Value, by Application (2019-2030)
        4.2.3 Global Companion Diagnostic Technologies Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Companion Diagnostic Technologies Sales Value by Region
        5.1.1 Global Companion Diagnostic Technologies Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Companion Diagnostic Technologies Sales Value by Region (2019-2024)
        5.1.3 Global Companion Diagnostic Technologies Sales Value by Region (2025-2030)
        5.1.4 Global Companion Diagnostic Technologies Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Companion Diagnostic Technologies Sales Value, 2019-2030
        5.2.2 North America Companion Diagnostic Technologies Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Companion Diagnostic Technologies Sales Value, 2019-2030
        5.3.2 Europe Companion Diagnostic Technologies Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Companion Diagnostic Technologies Sales Value, 2019-2030
        5.4.2 Asia Pacific Companion Diagnostic Technologies Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Companion Diagnostic Technologies Sales Value, 2019-2030
        5.5.2 South America Companion Diagnostic Technologies Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Companion Diagnostic Technologies Sales Value, 2019-2030
        5.6.2 Middle East & Africa Companion Diagnostic Technologies Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Companion Diagnostic Technologies Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Companion Diagnostic Technologies Sales Value
    6.3 United States
        6.3.1 United States Companion Diagnostic Technologies Sales Value, 2019-2030
        6.3.2 United States Companion Diagnostic Technologies Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Companion Diagnostic Technologies Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Companion Diagnostic Technologies Sales Value, 2019-2030
        6.4.2 Europe Companion Diagnostic Technologies Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Companion Diagnostic Technologies Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Companion Diagnostic Technologies Sales Value, 2019-2030
        6.5.2 China Companion Diagnostic Technologies Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Companion Diagnostic Technologies Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Companion Diagnostic Technologies Sales Value, 2019-2030
        6.6.2 Japan Companion Diagnostic Technologies Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Companion Diagnostic Technologies Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Companion Diagnostic Technologies Sales Value, 2019-2030
        6.7.2 South Korea Companion Diagnostic Technologies Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Companion Diagnostic Technologies Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Companion Diagnostic Technologies Sales Value, 2019-2030
        6.8.2 Southeast Asia Companion Diagnostic Technologies Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Companion Diagnostic Technologies Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Companion Diagnostic Technologies Sales Value, 2019-2030
        6.9.2 India Companion Diagnostic Technologies Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Companion Diagnostic Technologies Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Dako (Agilent Technologies)
        7.1.1 Dako (Agilent Technologies) Profile
        7.1.2 Dako (Agilent Technologies) Main Business
        7.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Products, Services and Solutions
        7.1.4 Dako (Agilent Technologies) Companion Diagnostic Technologies Revenue (US$ Million) & (2019-2024)
        7.1.5 Dako (Agilent Technologies) Recent Developments
    7.2 Qiagen
        7.2.1 Qiagen Profile
        7.2.2 Qiagen Main Business
        7.2.3 Qiagen Companion Diagnostic Technologies Products, Services and Solutions
        7.2.4 Qiagen Companion Diagnostic Technologies Revenue (US$ Million) & (2019-2024)
        7.2.5 Qiagen Recent Developments
    7.3 Roche
        7.3.1 Roche Profile
        7.3.2 Roche Main Business
        7.3.3 Roche Companion Diagnostic Technologies Products, Services and Solutions
        7.3.4 Roche Companion Diagnostic Technologies Revenue (US$ Million) & (2019-2024)
        7.3.5 Abbott Laboratories Recent Developments
    7.4 Abbott Laboratories
        7.4.1 Abbott Laboratories Profile
        7.4.2 Abbott Laboratories Main Business
        7.4.3 Abbott Laboratories Companion Diagnostic Technologies Products, Services and Solutions
        7.4.4 Abbott Laboratories Companion Diagnostic Technologies Revenue (US$ Million) & (2019-2024)
        7.4.5 Abbott Laboratories Recent Developments
    7.5 Thermo Fisher Scientific
        7.5.1 Thermo Fisher Scientific Profile
        7.5.2 Thermo Fisher Scientific Main Business
        7.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Products, Services and Solutions
        7.5.4 Thermo Fisher Scientific Companion Diagnostic Technologies Revenue (US$ Million) & (2019-2024)
        7.5.5 Thermo Fisher Scientific Recent Developments
    7.6 bioMerieux
        7.6.1 bioMerieux Profile
        7.6.2 bioMerieux Main Business
        7.6.3 bioMerieux Companion Diagnostic Technologies Products, Services and Solutions
        7.6.4 bioMerieux Companion Diagnostic Technologies Revenue (US$ Million) & (2019-2024)
        7.6.5 bioMerieux Recent Developments
    7.7 Myriad Genetics
        7.7.1 Myriad Genetics Profile
        7.7.2 Myriad Genetics Main Business
        7.7.3 Myriad Genetics Companion Diagnostic Technologies Products, Services and Solutions
        7.7.4 Myriad Genetics Companion Diagnostic Technologies Revenue (US$ Million) & (2019-2024)
        7.7.5 Myriad Genetics Recent Developments
    7.8 Resonance Health Ltd.
        7.8.1 Resonance Health Ltd. Profile
        7.8.2 Resonance Health Ltd. Main Business
        7.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Products, Services and Solutions
        7.8.4 Resonance Health Ltd. Companion Diagnostic Technologies Revenue (US$ Million) & (2019-2024)
        7.8.5 Resonance Health Ltd. Recent Developments
    7.9 Leica Microsystems
        7.9.1 Leica Microsystems Profile
        7.9.2 Leica Microsystems Main Business
        7.9.3 Leica Microsystems Companion Diagnostic Technologies Products, Services and Solutions
        7.9.4 Leica Microsystems Companion Diagnostic Technologies Revenue (US$ Million) & (2019-2024)
        7.9.5 Leica Microsystems Recent Developments
    7.10 Danaher
        7.10.1 Danaher Profile
        7.10.2 Danaher Main Business
        7.10.3 Danaher Companion Diagnostic Technologies Products, Services and Solutions
        7.10.4 Danaher Companion Diagnostic Technologies Revenue (US$ Million) & (2019-2024)
        7.10.5 Danaher Recent Developments

 8 Industry Chain Analysis
    8.1 Companion Diagnostic Technologies Industrial Chain
    8.2 Companion Diagnostic Technologies Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Companion Diagnostic Technologies Sales Model
        8.5.2 Sales Channel
        8.5.3 Companion Diagnostic Technologies Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Companion Diagnostic Technologies Market Trends
    Table 2. Companion Diagnostic Technologies Market Drivers & Opportunity
    Table 3. Companion Diagnostic Technologies Market Challenges
    Table 4. Companion Diagnostic Technologies Market Restraints
    Table 5. Global Companion Diagnostic Technologies Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Companion Diagnostic Technologies Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Companion Diagnostic Technologies Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Companion Diagnostic Technologies Product Type
    Table 9. Key Companies Time to Begin Mass Production of Companion Diagnostic Technologies
    Table 10. Global Companion Diagnostic Technologies Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Technologies as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Companion Diagnostic Technologies Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Companion Diagnostic Technologies Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Companion Diagnostic Technologies Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Companion Diagnostic Technologies Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Companion Diagnostic Technologies Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Companion Diagnostic Technologies Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Companion Diagnostic Technologies Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Companion Diagnostic Technologies Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Companion Diagnostic Technologies Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Companion Diagnostic Technologies Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Companion Diagnostic Technologies Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Companion Diagnostic Technologies Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Companion Diagnostic Technologies Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Companion Diagnostic Technologies Sales Value by Region (2019-2024) & (%)
    Table 27. Global Companion Diagnostic Technologies Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Companion Diagnostic Technologies Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Companion Diagnostic Technologies Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Companion Diagnostic Technologies Sales Value, (2025-2030) & (US$ Million)
    Table 31. Dako (Agilent Technologies) Basic Information List
    Table 32. Dako (Agilent Technologies) Description and Business Overview
    Table 33. Dako (Agilent Technologies) Companion Diagnostic Technologies Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Companion Diagnostic Technologies Business of Dako (Agilent Technologies) (2019-2024)
    Table 35. Dako (Agilent Technologies) Recent Developments
    Table 36. Qiagen Basic Information List
    Table 37. Qiagen Description and Business Overview
    Table 38. Qiagen Companion Diagnostic Technologies Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Companion Diagnostic Technologies Business of Qiagen (2019-2024)
    Table 40. Qiagen Recent Developments
    Table 41. Roche Basic Information List
    Table 42. Roche Description and Business Overview
    Table 43. Roche Companion Diagnostic Technologies Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Companion Diagnostic Technologies Business of Roche (2019-2024)
    Table 45. Roche Recent Developments
    Table 46. Abbott Laboratories Basic Information List
    Table 47. Abbott Laboratories Description and Business Overview
    Table 48. Abbott Laboratories Companion Diagnostic Technologies Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Companion Diagnostic Technologies Business of Abbott Laboratories (2019-2024)
    Table 50. Abbott Laboratories Recent Developments
    Table 51. Thermo Fisher Scientific Basic Information List
    Table 52. Thermo Fisher Scientific Description and Business Overview
    Table 53. Thermo Fisher Scientific Companion Diagnostic Technologies Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Companion Diagnostic Technologies Business of Thermo Fisher Scientific (2019-2024)
    Table 55. Thermo Fisher Scientific Recent Developments
    Table 56. bioMerieux Basic Information List
    Table 57. bioMerieux Description and Business Overview
    Table 58. bioMerieux Companion Diagnostic Technologies Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Companion Diagnostic Technologies Business of bioMerieux (2019-2024)
    Table 60. bioMerieux Recent Developments
    Table 61. Myriad Genetics Basic Information List
    Table 62. Myriad Genetics Description and Business Overview
    Table 63. Myriad Genetics Companion Diagnostic Technologies Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Companion Diagnostic Technologies Business of Myriad Genetics (2019-2024)
    Table 65. Myriad Genetics Recent Developments
    Table 66. Resonance Health Ltd. Basic Information List
    Table 67. Resonance Health Ltd. Description and Business Overview
    Table 68. Resonance Health Ltd. Companion Diagnostic Technologies Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Companion Diagnostic Technologies Business of Resonance Health Ltd. (2019-2024)
    Table 70. Resonance Health Ltd. Recent Developments
    Table 71. Leica Microsystems Basic Information List
    Table 72. Leica Microsystems Description and Business Overview
    Table 73. Leica Microsystems Companion Diagnostic Technologies Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Companion Diagnostic Technologies Business of Leica Microsystems (2019-2024)
    Table 75. Leica Microsystems Recent Developments
    Table 76. Danaher Basic Information List
    Table 77. Danaher Description and Business Overview
    Table 78. Danaher Companion Diagnostic Technologies Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Companion Diagnostic Technologies Business of Danaher (2019-2024)
    Table 80. Danaher Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Companion Diagnostic Technologies Downstream Customers
    Table 84. Companion Diagnostic Technologies Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Companion Diagnostic Technologies Product Picture
    Figure 2. Global Companion Diagnostic Technologies Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Companion Diagnostic Technologies Sales Value (2019-2030) & (US$ Million)
    Figure 4. Companion Diagnostic Technologies Report Years Considered
    Figure 5. Global Companion Diagnostic Technologies Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Companion Diagnostic Technologies Revenue in 2023
    Figure 7. Companion Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Immunohistochemistry Picture
    Figure 9. Molecular Diagnostics Picture
    Figure 10. Global Companion Diagnostic Technologies Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Companion Diagnostic Technologies Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Oncology
    Figure 13. Product Picture of Cardiovascular
    Figure 14. Product Picture of Central Nervous System
    Figure 15. Product Picture of Auto immune & Inflammation
    Figure 16. Product Picture of Virology
    Figure 17. Product Picture of Others
    Figure 18. Global Companion Diagnostic Technologies Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Companion Diagnostic Technologies Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Companion Diagnostic Technologies Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Companion Diagnostic Technologies Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Companion Diagnostic Technologies Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Companion Diagnostic Technologies Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Companion Diagnostic Technologies Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Companion Diagnostic Technologies Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Companion Diagnostic Technologies Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Companion Diagnostic Technologies Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Companion Diagnostic Technologies Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Companion Diagnostic Technologies Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Companion Diagnostic Technologies Sales Value (%), (2019-2030)
    Figure 31. United States Companion Diagnostic Technologies Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Companion Diagnostic Technologies Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Companion Diagnostic Technologies Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Companion Diagnostic Technologies Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Companion Diagnostic Technologies Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Companion Diagnostic Technologies Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Companion Diagnostic Technologies Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Companion Diagnostic Technologies Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Companion Diagnostic Technologies Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Companion Diagnostic Technologies Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Companion Diagnostic Technologies Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Companion Diagnostic Technologies Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Companion Diagnostic Technologies Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Companion Diagnostic Technologies Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Companion Diagnostic Technologies Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Companion Diagnostic Technologies Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Companion Diagnostic Technologies Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Companion Diagnostic Technologies Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Companion Diagnostic Technologies Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Companion Diagnostic Technologies Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Companion Diagnostic Technologies Sales Value by Application (%), 2023 VS 2030
    Figure 52. Companion Diagnostic Technologies Industrial Chain
    Figure 53. Companion Diagnostic Technologies Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation

Description

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment.

The global market for Companion Diagnostic Technologies was estimated to be worth US$ 2771.3 million in 2023 and is forecast to a readjusted size of US$ 6057.7 million by 2030 with a CAGR of 11.3% during the forecast period 2024-2030

Market Segmentation